Nabumetone use and risk of acute pancreatitis in a case-control study

Pancreatology

Volumn 16, Issue 3, 2016, Pages 353-357

  Hung, Shih Chang ^a,b   Liao, Kuan Fu ^c,d,e   Hung, Hung Chang ^a   Lin, Cheng Li ^f,g   Lai, Shih Wei ^f,g   Lin, Chih Hsueh ^f,g  

^a Nantou Hospital   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adverse effect; Epidemiology; NSAID; Pancreatitis; Risk; Safety

Indexed keywords

NABUMETONE; ALKANONE; CYCLOOXYGENASE 2 INHIBITOR;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; ACUTE DISEASE; CHEMICALLY INDUCED; FACTUAL DATABASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATITIS; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BUTANONES; CASE-CONTROL STUDIES; CYCLOOXYGENASE 2 INHIBITORS; DATABASES, FACTUAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATITIS; RISK FACTORS; TAIWAN;

EID: 84961589888     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2016.03.003     Document Type: Article

References (33)

1. P.J. Fagenholz, C. Fernandez-del Castillo, N.S. Harris, A.J. Pelletier, and C.A. Camargo Jr. Direct medical costs of acute pancreatitis hospitalizations in the united states Pancreas 35 2007 302 307
2. J. McNabb-Baltar, P. Ravi, G.A. Isabwe, S.L. Suleiman, M. Yaghoobi, Q.D. Trinh, and et al. A population-based assessment of the burden of acute pancreatitis in the united states Pancreas 43 2014 687 691
3. A.F. Peery, E.S. Dellon, J. Lund, S.D. Crockett, C.E. McGowan, W.J. Bulsiewicz, and et al. Burden of gastrointestinal disease in the united states: 2012 update Gastroenterology 143 2012 1179-1187.e1171-1173
4. B. Andersson, B. Appelgren, V. Sjodin, D. Ansari, J. Nilsson, U. Persson, and et al. Acute pancreatitis-costs for healthcare and loss of production Scand J Gastroenterol 48 2013 1459 1465
5. S. Hamada, A. Masamune, K. Kikuta, M. Hirota, I. Tsuji, and T. Shimosegawa Nationwide epidemiological survey of acute pancreatitis in japan Pancreas 43 2014 1244 1248
6. K. Satoh, T. Shimosegawa, A. Masamune, M. Hirota, K. Kikuta, Y. Kihara, and et al. Nationwide epidemiological survey of acute pancreatitis in japan Pancreas 40 2011 503 507
7. H.N. Shen, and C.L. Lu Incidence, resource use, and outcome of acute pancreatitis with/without intensive care: a nationwide population-based study in taiwan Pancreas 40 2011 10 15
8. H.N. Shen, C.L. Lu, and C.Y. Li Epidemiology of first-attack acute pancreatitis in taiwan from 2000 through 2009: a nationwide population-based study Pancreas 41 2012 696 702
9. B. Spanier, M.J. Bruno, and M.G. Dijkgraaf Incidence and mortality of acute and chronic pancreatitis in the netherlands: a nationwide record-linked cohort study for the years 1995-2005 World J Gastroenterol 19 2013 3018 3026
10. A.B. Lowenfels, P. Maisonneuve, and T. Sullivan The changing character of acute pancreatitis: epidemiology, etiology, and prognosis Curr Gastroenterol Rep 11 2009 97 103
11. J.L. Frossard, M.L. Steer, and C.M. Pastor Acute pancreatitis Lancet (London, England) 371 2008 143 152
12. S. Tenner Drug induced acute pancreatitis: does it exist? World J Gastroenterol 20 2014 16529 16534
13. A.R. Balani, and J.H. Grendell Drug-induced pancreatitis: incidence, management and prevention Drug Saf 31 2008 823 837
14. I. Vinklerova, M. Prochazka, V. Prochazka, and K. Urbanek Incidence, severity, and etiology of drug-induced acute pancreatitis Dig Dis Sci 55 2010 2977 2981
15. C.D. Trivedi, and C.S. Pitchumoni Drug-induced pancreatitis: an update J Clin Gastroenterol 39 2005 709 716
16. eHealthMe: Review: Could nabumetone cause pancreatitis acute? eHealthMe.com. http://www.ehealthme.com/ds/nabumetone/pancreatitis+acute [cited in 2016 January].
17. National Health Research Institute (NHRI): National health insurance research database. Taiwan. http://nhird.nhri.org.tw/en/index.html [cited in 2015 December, English version].
18. S.C. Hung, K.F. Liao, S.W. Lai, C.I. Li, and W.C. Chen Risk factors associated with symptomatic cholelithiasis in taiwan: a population-based study BMC Gastroenterol 11 2011 111
19. S.W. Lai, K.F. Liao, C.C. Liao, C.H. Muo, C.S. Liu, and F.C. Sung Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study Medicine 89 2010 295 299
20. S.W. Lai, C.H. Muo, K.F. Liao, F.C. Sung, and P.C. Chen Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in taiwan Am J Gastroenterol 106 2011 1697 1704
21. MedLibrary.org: Nabumetone. http://medlibrary.org/lib/rx/meds/nabumetone/ [cited in 2016 January].
22. N. Badalov, R. Baradarian, K. Iswara, J. Li, W. Steinberg, and S. Tenner Drug-induced acute pancreatitis: an evidence-based review Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 5 2007 648 661 quiz 644
23. D. Yadav, G.I. Papachristou, and D.C. Whitcomb Alcohol-associated pancreatitis Gastroenterol Clin N Am 36 vii 2007 219 238
24. K. Wang, Z. Weng, L. Sun, J. Sun, S.F. Zhou, and L. He Systematic drug safety evaluation based on public genomic expression (connectivity map) data: myocardial and infectious adverse reactions as application cases Biochem Biophys Res Commun 457 2015 249 255
25. G. Ozhan, T.H. Yanar, C. Ertekin, and B. Alpertunga The effect of genetic polymorphisms of cyclooxygenase 2 on acute pancreatitis in turkey Pancreas 39 2010 371 376
26. S.C. Hung, S.R. Hung, C.L. Lin, S.W. Lai, and H.C. Hung Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in taiwan Am J Gastroenterol 110 2015 1490 1496
27. S.W. Lai, C.L. Lin, and K.F. Liao Association of meloxicam use with the risk of acute pancreatitis: a case-control study Clin Drug Invest 35 2015 653 657
28. M. Feldman, and A.T. McMahon Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 132 2000 134 143
29. H.T. Sorensen, J. Jacobsen, M. Norgaard, L. Pedersen, S.P. Johnsen, and J.A. Baron Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis Aliment Pharmacol Ther 24 2006 111 116
30. R. Pezzilli, G. Uomo, A. Gabbrielli, A. Zerbi, L. Frulloni, P. De Rai, and et al. A prospective multicentre survey on the treatment of acute pancreatitis in italy Dig Liver Dis Off J Italian Soc Gastroenterol Italian Assoc Study Liver 39 2007 838 846
31. K.B. Blomgren, A. Sundstrom, G. Steineck, S. Genell, S. Sjostedt, and B.E. Wiholm A swedish case-control network for studies of drug-induced morbidity-acute pancreatitis Eur J Clin Pharmacol 58 2002 275 283
32. G. Hauser, M. Milosevic, D. Stimac, E. Zerem, P. Jovanovic, and I. Blazevic Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done? World J Gastroenterol 21 2015 1069 1080
33. K. Kume, A. Masamune, H. Ariga, and T. Shimosegawa Alcohol consumption and the risk for developing pancreatitis: a case-control study in japan Pancreas 44 2015 53 58